Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary
Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib)…
Don’t Miss Out On The Most Important Cannabis Investment Conference In The World, Tickets Going Fast And Going Up Soon
We're getting down to the wire so don't put off until tomorrow what you really should do today and save money. Also, think of the disappointment you'll experience if you miss out on this...the largest and most prestigious cannabis investment conference in the world.
4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed
Field Trip (NASDAQ: FTRP), Wesana (OTCQB: WSNAF), Braxia (OTC: BRAXF) and
This Women Health Stock Gets Analyst Downgrade On ‘Approvability Issues, Restructuring’
HC Wainwright has downgraded ObsEva SA (NASDAQ:OBSV) from a Buy to Neutral without a price target. Late last month, the FDA notified…
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
U.S. stocks extended losses toward the end of trading, with the Nasdaq Composite dropping around 200 points on Tuesday
This Trump Ally’s Hard Stance Against Cannabis May Impact These Companies After Election Day
Cannabis is in the spotlight of many debates these days, especially in Pennsylvania where Republican gubernatorial candidate Doug Mastriano is running against Democratic nominee, Attorney General Josh Shapiro.
Analyst Hikes Price Target, Expects Rockwell Medical To Take Steps To Improve Debt Position
HC Wainwright has increased the price target on Rockwell Medical Inc (NASDAQ:RMTI) from $3 to $8, with a Buy rating, reflecting a 1-for-11…
Why This Azure Power Analyst Is Turning Bearish, Slashing Price Target
Azure Power Global Ltd’s (NYSE: AZRE) CEO resigned merely two months after assuming the role, and there is lack of visibility around the company’s long-term plans, according to Credit Suisse.
Why Lose Money In A Bear Market? These Stocks Are Bucking The Trend In 2022
Contrary to 2021, when equity markets were in a bull run, 2022 has served as a not-so-gentle reminder that the stock market does not give free gifts. The macro attitude that is pushing the markets lower has been influenced by worries about a recession, geopolitical tensions, the energy crisis, and record inflation.
US Stocks Turn Lower; Dow Dips Over 200 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday